Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 7/7/2020
SIETES contiene 93061 citas

 1 a 12 de 12 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Harrison-Woolrych M, Woolley J. New study supports MHRA advice on combined oral contraceptives. BMJ 2015;350:h3305. [Ref.ID 99220]
2.Tiene citas relacionadas
Harrison-Woolrych M. Varenicline for smoking cessation. BMJ 2012;345:9. [Ref.ID 94079]
3.Enlace a cita original Cita con resumen
Harrison-Woolrych M, Härmark L, Tan M, Maggo S, van Grootheest K. Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres. Eur J Clin Pharmacol 2012;67:1065-72. [Ref.ID 93350]
4. Cita con resumen
Harrison-Woolrych M, Maggo S, Tan M, Savage R, Ashton J. Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand. Drug Saf 2012;35:33-43. [Ref.ID 92243]
7. Cita con resumen
Harrison-Woolrych M. Varenicline and suicide. Safety data from New Zealand. BMJ 2010;340:117-8. [Ref.ID 87628]
8. Cita con resumen
Harrison-Woolrych M, García-Quirga J, Ashton J, Herbison P. Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort study. Drug Saf 2007;30:569-79. [Ref.ID 80670]
Harrison-Woolrych M, Clark DWJ, Hill GR, Rees MI, Skinner JR. QT interval prolongation associated with sibutramine treatment. Br J Clin Pharmacol 2006;61:464-9. [Ref.ID 76498]
Clark DW, Harrison-Woolrych M. Sibutramine may be associated with memory impairment. BMJ 2004;329:1316. [Ref.ID 72084]
Harrison-Woolrych M, Duncan A, Smith C. Improving access to emergency contraception. BMJ 2001;322:186-7. [Ref.ID 54970]
Seleccionar todas
 1 a 12 de 12